Sanofi (SNYN) - Total Liabilities

Latest as of June 2026: MX$59.49 Billion MXN ≈ $3.42 Billion USD

Based on the latest financial reports, Sanofi (SNYN) has total liabilities worth MX$59.49 Billion MXN (≈ $3.42 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Sanofi to see how much of total assets are deployed in long-term investments.

Sanofi - Total Liabilities Trend (2013–2025)

This chart illustrates how Sanofi's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SNYN current and non-current assets.

Sanofi Competitors by Total Liabilities

The table below lists competitors of Sanofi ranked by their total liabilities.

Company	Country	Total Liabilities
CVS Health Corp NYSE:CVS	USA	$185.68 Billion
GlaxoSmithKline plc MX:GSKN	Mexico	MX$45.59 Billion
Equinix Inc NASDAQ:EQIX	USA	$26.70 Billion
Spotify Technology SA NYSE:SPOT	USA	$5.36 Billion
CME Group Inc NASDAQ:CME	USA	$175.38 Billion
State Bank of India NSE:SBIN	India	Rs72.70 Trillion
HDFC Bank Limited F:HDFA	Germany	€43.46 Trillion
Adobe Systems Incorporated NASDAQ:ADBE	USA	$18.41 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Sanofi's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SNYN equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.99	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sanofi's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sanofi (2013–2025)

The table below shows the annual total liabilities of Sanofi from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	MX$55.09 Billion ≈ $3.17 Billion	+0.28%
2024-12-31	MX$54.94 Billion ≈ $3.16 Billion	+5.43%
2023-12-31	MX$52.11 Billion ≈ $3.00 Billion	+2.03%
2022-12-31	MX$51.07 Billion ≈ $2.94 Billion	-0.27%
2021-12-31	MX$51.21 Billion ≈ $2.95 Billion	-0.33%
2020-12-31	MX$51.38 Billion ≈ $2.96 Billion	-4.19%
2019-12-31	MX$53.63 Billion ≈ $3.09 Billion	+2.40%
2018-12-31	MX$52.37 Billion ≈ $3.01 Billion	+25.99%
2017-12-31	MX$41.57 Billion ≈ $2.39 Billion	-11.46%
2016-12-31	MX$46.95 Billion ≈ $2.70 Billion	+6.43%
2015-12-31	MX$44.11 Billion ≈ $2.54 Billion	+7.26%
2014-12-31	MX$41.12 Billion ≈ $2.37 Billion	+5.39%
2013-12-31	MX$39.02 Billion ≈ $2.25 Billion	--

About Sanofi

MX:SNYN Mexico Drug Manufacturers - General

Market Cap

$100.25 Billion

MX$1.74 Trillion MXN

Market Cap Rank

#257 Global

#9 in Mexico

Share Price

MX$727.00

Change (1 day)

-0.82%

52-Week Range

MX$727.00 - MX$955.00

All Time High

MX$1212.00